Pope Nicolas H, Salmon Morgan, Davis John P, Chatterjee Anuran, Su Gang, Conte Michael S, Ailawadi Gorav, Upchurch Gilbert R
Department of Surgery, University of Virginia, Charlottesville, Virginia, USA; and.
Department of Surgery, Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, California, USA.
FASEB J. 2016 Dec;30(12):4192-4201. doi: 10.1096/fj.201600144RR. Epub 2016 Sep 12.
The role of resolvins in abdominal aortic aneurysm (AAA) has not been established. We hypothesized that treatment with D-series resolvins (RvD2 or RvD1) would attenuate murine AAA formation through alterations in macrophage polarization and cytokine expression. Male C57/B6 mice (n = 9 per group) 8 to 12 wk old received RvD2 (100 ng/kg/treatment), RvD1 (100 ng/kg/treatment), or vehicle only every third day beginning 3 d before abdominal aortic perfusion with elastase as prevention. Aortas were collected 14 d after elastase perfusion. Cytokine analysis (n = 5 per group) or confocal microscopy (n = 4 per group) was performed. In a separate experiment, RvD2 was provided to mice with small AAAs 3 d after elastase treatment (n = 8 per group). Additionally, apolipoprotein E knockout mice treated with angiotensin II (1000 ng/kg) were treated with RvD2 or vehicle alone (n = 10 per group) in a nonsurgical model of AAA. To determine the effect of RvD2 on macrophage polarization, confocal staining for macrophages, M1 and M2 macrophage subtypes, α-actin, and DAPI was performed. Mean aortic dilation was 96 ± 13% for vehicle-treated mice, 57 ± 9.7% for RvD2-treated mice, and 61 ± 11% for RvD1-treated mice (P < 0.0001). Proinflammatory cytokines macrophage chemotactic protein 1, C-X-C motif ligand 1, and IL-1β were significantly elevated in control animals compared to RvD2- and RvD1-treated animals (P < 0.05), resulting in a reduction of matrix metalloproteinase 2 and 9 activity in resolvin-treated mice in both elastase and angiotensin II models. Treatment of existing small AAAs with RvD2 demonstrated a 25% reduction in aneurysm size at d 14 compared to vehicle alone (P = 0.018). Confocal histology demonstrated a prevalence of M2 macrophages within the aortic medium in mice treated with RvD2. Resolvin D2 exhibits a potent protective effect against experimental AAA formation. Treatment with RvD2 significantly influences macrophage polarization and decreases several important proinflammatory cytokines. Resolvins and the alteration of macrophage polarization represent potential future targets for prevention of AAA.-Pope, N. H., Salmon, M., Davis, J. P., Chatterjee, A., Su, G., Conte, M. S., Ailawadi, G., Upchurch, G. R., Jr. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.
消退素在腹主动脉瘤(AAA)中的作用尚未明确。我们推测,用D系列消退素(RvD2或RvD1)进行治疗可通过改变巨噬细胞极化和细胞因子表达来减轻小鼠AAA的形成。8至12周龄的雄性C57/B6小鼠(每组n = 9只)在腹主动脉灌注弹性蛋白酶前3天开始,每隔一天接受RvD2(100 ng/kg/次)、RvD1(100 ng/kg/次)或仅接受赋形剂,作为预防措施。弹性蛋白酶灌注14天后收集主动脉。进行细胞因子分析(每组n = 5只)或共聚焦显微镜检查(每组n = 4只)。在另一项实验中,弹性蛋白酶处理3天后,给患有小AAA的小鼠提供RvD2(每组n = 8只)。此外,在AAA的非手术模型中,用血管紧张素II(1000 ng/kg)处理的载脂蛋白E基因敲除小鼠分别接受RvD2或仅接受赋形剂处理(每组n = 10只)。为了确定RvD2对巨噬细胞极化的影响,对巨噬细胞、M1和M2巨噬细胞亚型、α-肌动蛋白和DAPI进行了共聚焦染色。接受赋形剂处理的小鼠主动脉平均扩张为96±13%,接受RvD2处理的小鼠为57±9.7%,接受RvD1处理的小鼠为61±11%(P < 0.0001)。与接受RvD2和RvD1处理的动物相比,对照组动物中促炎细胞因子巨噬细胞趋化蛋白1、C-X-C基序配体1和IL-1β显著升高(P < 0.05),这导致在弹性蛋白酶和血管紧张素II模型中,接受消退素处理的小鼠体内基质金属蛋白酶2和9的活性降低。用RvD2治疗现有的小AAA,与仅接受赋形剂相比,在第14天时动脉瘤大小减少了25%(P = 0.018)。共聚焦组织学显示,接受RvD2处理的小鼠主动脉中层存在M2巨噬细胞。消退素D2对实验性AAA的形成具有强大的保护作用。用RvD2治疗可显著影响巨噬细胞极化,并降低几种重要的促炎细胞因子。消退素和巨噬细胞极化的改变代表了未来预防AAA的潜在靶点。-波普,N.H.,萨尔蒙,M.,戴维斯,J.P.,查特吉,A.,苏,G.,孔特,M.S.,艾拉瓦迪,G.,厄普丘奇,G.R.,小。D系列消退素抑制小鼠腹主动脉瘤形成并增加M2巨噬细胞极化